Identity and percentage holding of significant shareholders
| Substantial holdings | Shares held | % |
|---|---|---|
| Global Health Investment Fund I, LLC | 7,100,000 | 13.66% |
| Calculus Capital | 4,669,282 | 10.41%* |
| BGF Investment Management Limited | 3,306,770 | 6.361% * |
| Spreadex Ltd | 2,456,147 | 4.73%** |
| Mr Hugh JJ Rylands | 1,686,603 | 3.73% |
| Directors and related shareholders | ||
| Ian Gilham | 503,174 | 0.97% |
| David Budd | 213,710 | 0.41% |
| Matthew Fowler | 99,457 | 0.19% |
| Tom Lindsay | 202,217 | 0.39% |
| Chris Yates | 41,304 | 0.08% |
| Total Directors' holdings | 1,060,362 | 2.04% |
| Total shares in issue | 51,986,071 | 100.00% |
* - DATE OF LAST NOTIFICATION
** - Note 845,460 of these shares are held via a CFD/Spreadbet
Shareholder information
genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.
Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.
Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 51,986,701.
Number of AIM securities not in public hands is 1,060,362 or 2.0%.
Latest reports
16 June 2020
Investor Presentation June 2020
Investor News
Friday July 10, 2020
FTSE 100 up on day but lower over week as markets cheer potential coronavirus treatment
Friday July 10, 2020
Proactive news headlines: IQ-AI, Canadian Overseas Petroleum, Arix Bioscience, Eden Research …
Friday July 10, 2020
This site uses cookies for tracking and statistical purposes. Please read our 